chr1-202966850-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_016243.3(CYB5R1):c.64G>A(p.Gly22Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000991 in 1,613,748 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016243.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYB5R1 | NM_016243.3 | c.64G>A | p.Gly22Ser | missense_variant | 2/9 | ENST00000367249.9 | NP_057327.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYB5R1 | ENST00000367249.9 | c.64G>A | p.Gly22Ser | missense_variant | 2/9 | 1 | NM_016243.3 | ENSP00000356218.4 | ||
CYB5R1 | ENST00000473599.5 | n.134G>A | non_coding_transcript_exon_variant | 2/5 | 3 | |||||
CYB5R1 | ENST00000478009.1 | n.84G>A | non_coding_transcript_exon_variant | 2/3 | 2 | |||||
CYB5R1 | ENST00000482572.5 | n.102G>A | non_coding_transcript_exon_variant | 2/8 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152168Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000160 AC: 4AN: 249662Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135180
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1461580Hom.: 0 Cov.: 32 AF XY: 0.0000138 AC XY: 10AN XY: 727084
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152168Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74332
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 16, 2024 | The c.64G>A (p.G22S) alteration is located in exon 2 (coding exon 2) of the CYB5R1 gene. This alteration results from a G to A substitution at nucleotide position 64, causing the glycine (G) at amino acid position 22 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at